FDA Approves Pfizer’s COVID Booster for Children

 Newest authorization keeps younger demographic vaccinated The Food and Drug Administration (FDA) announced on Tuesday that they have approved Pfizer and BioNTech’s COVID-19 vaccine booster shot for children…

Read More

Supreme Court Lifts Personal Loan Restrictions for Campaigns

Rules 6-3 in favor of First Amendment right to political speech. This week, the Supreme Court ruled in favor of Senator Ted Cruz in a vote of 6-3…

Read More

Secretary Cardona Announces 2022 U.S. Presidential Scholars

161 high school seniors selected from 5,000 candidates. This month, Secretary of Education Miguel Cardona announced the high school seniors selected to be the 58th class of U.S.…

Read More

President`s Today Schedule – May 23, 2022

1:00 AM ET: The President holds a press conference with Prime Minister Kishida Fumio of Japan 1:40 AM ET: The President and Prime Minister Kishida Fumio of Japan…

Read More

Department of Commerce Releases Sales Report

Market unstable, but balanced by consumer spending The Department of Commerce released its monthly sales report last week, showing that consumer spending was surprisingly strong in the midst…

Read More

Monday, May 23

Today, President Joe Biden is preparing to take part in the second Quadrilateral Security Dialogue (QUAD) summit between the US, Japan, Australia, and India. The president is planning…

Read More

Believer’s Responsibility

Thank God for His wonderful works.

Read More

National Average Gas Price Continues to Climb

Experts anticipate the cost to reach $6 per gallon by August. Analysts at JPMorgan-Chase predict another surge in gasoline prices this summer, saying drivers across the nation could…

Read More

William Lietzau, Defense Counterintelligence and Security Agency

William Lietzau is Director of the Defense Counterintelligence and Security Agency. His office conducts personnel security investigations, supervises industrial security, and performs security education and awareness training. We pray…

Read More

FDA Rejects Antidepressant as COVID Treatment

Request for approval submitted by University of Minnesota professor. The Food and Drug Administration (FDA) published a document last week that declined the emergency use authorization of the…

Read More
Back to top
FE3